Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation.

Moreno-Navarrete JM, Escoté X, Ortega F, Camps M, Ricart W, Zorzano A, Vendrell J, Vidal-Puig A, Fernández-Real JM.

Diabetologia. 2015 Oct;58(10):2424-34. doi: 10.1007/s00125-015-3692-7. Epub 2015 Jul 23.

PMID:
26201685
2.

A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.

Moreno-Navarrete JM, Escoté X, Ortega F, Serino M, Campbell M, Michalski MC, Laville M, Xifra G, Luche E, Domingo P, Sabater M, Pardo G, Waget A, Salvador J, Giralt M, Rodriguez-Hermosa JI, Camps M, Kolditz CI, Viguerie N, Galitzky J, Decaunes P, Ricart W, Frühbeck G, Villarroya F, Mingrone G, Langin D, Zorzano A, Vidal H, Vendrell J, Burcelin R, Vidal-Puig A, Fernández-Real JM.

Diabetologia. 2013 Nov;56(11):2524-37. doi: 10.1007/s00125-013-3015-9. Epub 2013 Aug 21.

PMID:
23963324
3.

Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.

Gavaldà-Navarro A, Moreno-Navarrete JM, Quesada-López T, Cairó M, Giralt M, Fernández-Real JM, Villarroya F.

Diabetologia. 2016 Oct;59(10):2208-18. doi: 10.1007/s00125-016-4028-y. Epub 2016 Jun 25.

PMID:
27344313
4.

The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.

Pahwa R, Devaraj S, Jialal I.

Int J Obes (Lond). 2016 Jun;40(6):907-11. doi: 10.1038/ijo.2016.32. Epub 2016 Feb 16.

PMID:
26880233
5.

Adipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature.

Moreno-Navarrete JM, Jové M, Padró T, Boada J, Ortega F, Ricart W, Pamplona R, Badimón L, Portero-Otín M, Fernández-Real JM.

Obesity (Silver Spring). 2017 Feb;25(2):391-400. doi: 10.1002/oby.21711. Epub 2016 Dec 21.

7.

MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation.

Ge Q, Gérard J, Noël L, Scroyen I, Brichard SM.

Endocrinology. 2012 Nov;153(11):5285-96. doi: 10.1210/en.2012-1623. Epub 2012 Sep 26.

PMID:
23015294
8.

Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer X, Laguna JC, Michalik L, Wahli W, Vázquez-Carrera M.

Diabetes. 2008 Aug;57(8):2149-57. doi: 10.2337/db08-0176. Epub 2008 Apr 28.

9.

Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome.

Jialal I, Devaraj S, Bettaieb A, Haj F, Adams-Huet B.

Atherosclerosis. 2015 Jul;241(1):130-7. doi: 10.1016/j.atherosclerosis.2015.04.814. Epub 2015 May 1.

PMID:
25978344
10.

Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.

Chao LC, Bensinger SJ, Villanueva CJ, Wroblewski K, Tontonoz P.

Mol Endocrinol. 2008 Dec;22(12):2596-608. doi: 10.1210/me.2008-0161. Epub 2008 Oct 22.

11.

α-Naphthoflavone modulates inflammatory response in adipocytes-macrophages interaction through NFκB signaling.

Sun Y, Xie M, Huang T, Zhang X, Lei S, Shi Q, Wang S, Fan C, Zhang J.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7768-74. eCollection 2014.

12.

Lipopolysaccharide-Binding Protein Downregulates Fractalkine through Activation of p38 MAPK and NF-κB.

Huang X, Zeng Y, Jiang Y, Qin Y, Luo W, Xiang S, Sooranna SR, Pinhu L.

Mediators Inflamm. 2017;2017:9734837. doi: 10.1155/2017/9734837. Epub 2017 May 29.

13.
14.

Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression.

Wang L, Li L, Ran X, Long M, Zhang M, Tao Y, Luo X, Wang Y, Jiao Y, Mao X, Ren J.

Cardiovasc Toxicol. 2013 Dec;13(4):338-46. doi: 10.1007/s12012-013-9214-2.

PMID:
23686584
15.

Toll-like receptor 4 is involved in bacterial endotoxin-induced endothelial cell injury and SOC-mediated calcium regulation.

Sun R, Zhu Z, Su Q, Li T, Song Q.

Cell Biol Int. 2012 May 1;36(5):475-81. doi: 10.1042/CBI20110535.

PMID:
22288713
16.

Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line.

Siraj FM, SathishKumar N, Kim YJ, Kim SY, Yang DC.

J Enzyme Inhib Med Chem. 2015 Feb;30(1):9-14. doi: 10.3109/14756366.2013.871006. Epub 2014 Mar 25.

PMID:
24666293
17.
18.

Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes.

Wang M, Xiu L, Diao J, Wei L, Sun J.

Eur J Pharmacol. 2015 Dec 15;769:79-85. doi: 10.1016/j.ejphar.2015.10.050. Epub 2015 Oct 30.

PMID:
26522926
19.

Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells.

Kim GS, Park HJ, Woo JH, Kim MK, Koh PO, Min W, Ko YG, Kim CH, Won CK, Cho JH.

BMC Complement Altern Med. 2012 Apr 3;12:31. doi: 10.1186/1472-6882-12-31.

20.

Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.

Sato H, Ishikawa M, Funaki A, Kimura Y, Yoshida H, Fukata H, Hasegawa H, Ueno K.

Nutr Res. 2013 Nov;33(11):922-31. doi: 10.1016/j.nutres.2013.07.012. Epub 2013 Aug 15.

PMID:
24176232

Supplemental Content

Support Center